Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease-Reference-Cited by-同舟云学术

Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease

Published:2013-06-20 Issue:25 Volume:121 Page:5098-5103
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Inamoto Yoshihiro¹,Storer Barry E.¹²,Petersdorf Effie W.¹³,Nelson J. Lee¹⁴,Lee Stephanie J.¹³,Carpenter Paul A.¹⁵,Sandmaier Brenda M.¹³,Hansen John A.¹³,Martin Paul J.¹³,Flowers Mary E. D.¹³

Affiliation:

1. Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA; and

2. Department of Biostatistics,

3. Department of Medicine,

4. Department of Hematology, and

5. Department of Pediatrics, University of Washington School of Medicine, Seattle, WA

Abstract

Key Points Incidence of sclerotic GVHD is 20% by 3 years after initial systemic treatment for chronic GVHD. The use of mobilized blood cell graft and total body irradiation conditioning are associated with an increased risk of sclerotic GVHD.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/121/25/5098/1367193/5098.pdf

Reference28 articles.

1. Sjögren-type syndrome after allogeneic bone-marrow transplantation.;Gratwohl;Ann Intern Med,1977

2. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.;Shulman;Biol Blood Marrow Transplant,2006

3. Scleroderma.;Gabrielli;N Engl J Med,2009

4. Cutaneous chronic graft-versus-host disease does not have the abnormal endothelial phenotype or vascular rarefaction characteristic of systemic sclerosis.;Fleming;PLoS ONE,2009

5. Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease.;Biedermann;Lancet,2002

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Multicenter Phase II Trial of Ruxolitinib for Treatment of Corticosteroid Refractory Sclerotic Chronic Graft-Versus-Host Disease;Journal of Clinical Oncology;2024-08-16

2. Chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation;Pediatric Hematology/Oncology and Immunopathology;2024-07-22

3. The Application of Umbilical Cord Blood-derived Platelet Gel for Skin Ulcers Associated With Chronic Graft-Versus-Host Disease in Pediatrics: A Randomized Trial;Transplantation and Cellular Therapy;2024-07

4. Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease;JAMA Dermatology;2024-04-01

5. Characterization of orofacial features in sclerodermatous chronic graft‐versus‐host disease;Oral Diseases;2024-03-21